Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kristall distillery wants to IPO by the end of the year

10/2/23 KLVZ

AT&T announced a quarterly dividend

9/29/23 T

Surgutneftegaz reported for 6 months of 2023 by IFRS

9/29/23 SNGS

Surgutneftegaz reported for 6 months of 2023 by RAS

9/29/23 SNGS

Shareholders of Renaissance Insurance approved dividends for 6 months 2023

9/29/23 RENI

Yandex plans to open an offline store of its smart devices

9/29/23 YNDX

Carnival has reported for 9 months of 2023

9/29/23 CCL

SberMarket launched delivery in 200 more Russian cities

9/29/23 SBER

Pyatyorochka opened its 300th franchise store

9/29/23 FIVE

Rusolovo acquired a license for a tin-polymetallic site in Chukotka

9/29/23 ROLO